Literature DB >> 10417528

Paraneoplastic cicatricial pemphigoid.

J Setterfield1, P J Shirlaw, Z Lazarova, B M Bryant, B S Bhogal, K Harman, S J Challacombe, M M Black.   

Abstract

We report a 39-year-old woman with antiepiligrin cicatricial pemphigoid (CP) in association with non-small cell carcinoma of the lung. At presentation, mucosal lesions showed minimal response to combined systemic immunosuppressive agents. Following the diagnosis of non-small cell lung carcinoma and subsequent treatment with gemcitabine (a second-line chemotherapeutic agent), a significant reduction in both tumour mass and mucosal blistering was observed. Metastatic disease was subsequently associated with recurrent oral erosions. We believe this patient represents the first reported case of paraneoplastic CP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417528     DOI: 10.1046/j.1365-2133.1999.02933.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Cicatrising conjunctivitis due to paraneoplastic pemphigoid.

Authors:  Tina Rutar; Matilda F Chan; Nisha R Acharya; Ayman Naseri
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

2.  Mucous Membrane Pemphigoid-Associated Malignancies: Case Series and a Brief Overview of the Literature.

Authors:  Michelangelo La Placa; Riccardo Balestri; Federico Tartari; Andrea Sechi; Francesca Ferrara; Camilla Loi; Annalisa Patrizi; Federico Bardazzi
Journal:  Dermatol Pract Concept       Date:  2019-04-30

3.  Paraneoplastic mucous membrane pemphigoid with ocular and laryngeal involvement.

Authors:  Silvia Lambiel; Pavel Dulguerov; Emmanuel Laffitte; Igor Leuchter
Journal:  BMJ Case Rep       Date:  2017-08-11

4.  Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases.

Authors:  F Giurdanella; A M Nijenhuis; G F H Diercks; M F Jonkman; H H Pas
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.